突变LRRK2在实验性慢性大肠炎模型中加剧了免疫反应和神经退行

相关实验视频

Updated: Jun 27, 2026

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

Diego Cabezudo¹, George Tsafaras¹, Eva Van Acker¹

¹Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, Leuven Brain Institute, KU Leuven, Herestraat 49, box 1023, 3000, Leuven, Belgium.

Acta neuropathologica

|June 8, 2023

概括

富含白的重复激酶2 (LRRK2) 在肠道炎症和帕金森病 (PD) 中起着关键作用. 免疫细胞中的突变LRRK2会加剧结肠炎和神经炎症,影响PD的发病.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
胃肠病学胃肠病学

背景情况:

胃肠道功能障碍是帕金森病 (PD) 的早期症状.
炎症性肠病 (IBD) 是一种已知的PD风险因素.
氨酸丰富的重复激酶2 (LRRK2) 涉及到PD和IBD,在免疫细胞中表达高.

研究的目的:

研究LRRK2在肠道炎症中的作用及其与PD病变发生的联系.
检查LRRK2 G2019S突变对实验性结肠炎和神经炎症的影响.
在肠-大脑轴障碍的背景下,探索LRRK2在免疫细胞中的功能.

主要方法:

利用慢性硫酸 (DSS) 诱导的实验性结肠炎的小鼠模型.
使用骨髓移植来评估LRRK2在免疫细胞中的作用.
研究了药理学LRRK2抑制的影响.
分析了与肠道炎症和α-synuclein过度表达结合的神经炎症和多巴胺类神经退行.

主要成果:

在LRRK2 G2019S突变显著恶化结肠炎表型和炎症.
免疫细胞中的突变LRRK2对于大肠炎中恶化的炎症反应至关重要.
药理上抑制LRRK2激酶活性改善了结肠炎.
实验性结肠炎诱导神经炎症和免疫细胞透到大脑,特别是在G2019S小鼠中.
结合肠道炎症和α-synuclein过度表达,在G2019S小鼠中加剧了运动缺陷和神经退行.

结论:

LRRK2在肠道炎症 (结肠炎) 期间的免疫反应中发挥着中心作用.
受LRRK2影响的肠道炎症可能会导致与PD相关的神经炎症和神经退行.
这些发现突出了肠-大脑轴和LRRK2在PD病变发生过程中的作用.

关键词:

阿尔法-同核素是什么阿尔法-同核素炎症炎症是一种炎症.炎症性肠病是一种炎症性肠病.这是LRRK2 帕金森病是帕金森氏症的一种疾病.

更多相关视频

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on: June 2, 2021

相关概念视频

Inflammatory Bowel Disease II: Ulcerative Colitis

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...

Inflammatory Bowel Disease III: Crohn's Disease

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...